1. Home
  2. PSTV vs NIVF Comparison

PSTV vs NIVF Comparison

Compare PSTV & NIVF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PSTV
  • NIVF
  • Stock Information
  • Founded
  • PSTV 1996
  • NIVF 2011
  • Country
  • PSTV United States
  • NIVF Thailand
  • Employees
  • PSTV N/A
  • NIVF N/A
  • Industry
  • PSTV Medical/Dental Instruments
  • NIVF
  • Sector
  • PSTV Health Care
  • NIVF
  • Exchange
  • PSTV Nasdaq
  • NIVF NYSE
  • Market Cap
  • PSTV 8.6M
  • NIVF 9.8M
  • IPO Year
  • PSTV N/A
  • NIVF N/A
  • Fundamental
  • Price
  • PSTV $1.80
  • NIVF $1.05
  • Analyst Decision
  • PSTV Strong Buy
  • NIVF
  • Analyst Count
  • PSTV 1
  • NIVF 0
  • Target Price
  • PSTV $8.00
  • NIVF N/A
  • AVG Volume (30 Days)
  • PSTV 41.6K
  • NIVF 335.0K
  • Earning Date
  • PSTV 08-12-2024
  • NIVF 08-16-2024
  • Dividend Yield
  • PSTV N/A
  • NIVF N/A
  • EPS Growth
  • PSTV N/A
  • NIVF N/A
  • EPS
  • PSTV N/A
  • NIVF N/A
  • Revenue
  • PSTV $6,084,000.00
  • NIVF N/A
  • Revenue This Year
  • PSTV $5.21
  • NIVF N/A
  • Revenue Next Year
  • PSTV N/A
  • NIVF N/A
  • P/E Ratio
  • PSTV N/A
  • NIVF N/A
  • Revenue Growth
  • PSTV 733.42
  • NIVF N/A
  • 52 Week Low
  • PSTV $0.97
  • NIVF $0.64
  • 52 Week High
  • PSTV $3.21
  • NIVF $17.24
  • Technical
  • Relative Strength Index (RSI)
  • PSTV 52.81
  • NIVF 46.06
  • Support Level
  • PSTV $1.40
  • NIVF $1.01
  • Resistance Level
  • PSTV $1.59
  • NIVF $1.25
  • Average True Range (ATR)
  • PSTV 0.15
  • NIVF 0.09
  • MACD
  • PSTV 0.04
  • NIVF 0.04
  • Stochastic Oscillator
  • PSTV 83.03
  • NIVF 42.91

About PSTV PLUS THERAPEUTICS Inc.

Plus Therapeutics Inc is a clinical-stage pharmaceutical company that focuses on discovering, developing, and delivering complex treatments for patients with cancer and rare diseases. The company is working on a range of potential products, with its main programs targeting recurrent glioblastoma (GBM) and leptomeningeal metastases (LM). One of its key candidates, rhenium (186Re) obisbemeda, is specifically designed to treat central nervous system (CNS) cancers such as GBM, LM, and pediatric brain cancers (PBC).

About NIVF NEWGENIVF GROUP LIMITED

NewGenIvf Group Ltd is a company engaged in providing assisted reproductive services in Asia Pacific with a focus on providing fertility treatments to fulfil the dreams of building families, NewGenIvf mainly offers two services, namely first which is a in-vitro fertilization (IVF) treatment service, comprising traditional IVF and egg donation; and surrogacy and ancillary caring services.

Share on Social Networks: